Harvesting the medicinal potential of wild cucurbits
Dec. 2, 2014, Davis, CA — High-tech genomics and traditional Chinese medicine come together as researchers identify the genes responsible for the intense bitter taste of wild cucumbers.
Taming this bitterness made cucumber, pumpkin and their relatives into popular foods, but the same compounds also have potential to treat cancer and diabetes.
“You don’t eat wild cucumber, unless you want to use it as a purgative,” said William Lucas, professor of plant biology at the University of California, Davis, and co-author on the paper published Nov. 28 in the journal Science.
That bitter flavour in wild cucurbits – the family that includes cucumber, pumpkin, melon, watermelon and squash – is due to compounds called cucurbitacins.
The bitter taste protects wild plants against predators.
The fruit and leaves of wild cucurbits have been used in Indian and Chinese medicine for thousands of years, as emetics and purgatives and to treat liver disease.
CUCURBITACINS SHOWING POTENTIAL IN CANCER TREATMENT STUDIES
More recently, researchers have shown that cucurbitacins can kill or suppress growth of cancer cells.
Bitterness is known to be controlled by two genetic traits, “Bi” which confers bitterness on the whole plant, and “Bt,” which leads to bitter fruit.
In the new work, Lucas, Sanwen Huang at the Chinese Academy of Agricultural Sciences and colleagues employed the latest in DNA sequencing technology to identify the exact changes in DNA associated with bitterness.
They also tasted a great many cucumbers. “Luckily this is an easy trait to test for,” Lucas said. “You just chomp on a cucumber leaf of fruit and your tongue gives you the readout!”
NINE KEY GENES IDENTIFIED
They were able to identify nine genes involved in making cucurbitacin and show that the trait can be traced to two transcription factors that switch on these nine genes, in either leaves or the fruit, to produce cucurbitacin.
The new research shows how domestication tweaked cucumber genetics to make the fruit more edible. Understanding that process might open up approaches to developing other food crops based on plants that are naturally either inedible or poor in nutrition, Lucas said.
It could also make it much easier to produce cucurbitacins in large enough quantities to use in clinical trials and potentially in medicine, Lucas said.
For example the anti-malarial drug artemisinin, originally derived from traditional Chinese medicine, is now being produced either as a precursor molecule in yeast or through synthetic biology systems.
Other collaborators on the study included researchers at the Institute of Vegetables and Flowers, Beijing; Agricultural Genomics Institute, Shenzhen, China; Nanjing Agricultural University, Nanjing; Hunan Agricultural University, Changsha; Institute of Botany, Chinese Academy of Sciences, Beijing; Hunan Academy of Agricultural Sciences, Changsha; Wuhan University, Wuhan; Institute of Microbiology, Chinese Academy of Sciences, Beijing; Nihon University, Tokyo, Japan; and Wageningen University, Wageningen, The Netherlands.
• Related: Watermelon genome gives clues to disease resistance, plant vascular system
• Related: Cucumber genome published
• Lucas Laboratory
Subscription CentreNew Subscription Already a Subscriber Customer Service View Digital Magazine Renew
Narrowing down your pesky pest problemsWe all know what they say about assumptions. When diagnosing…
Greenhouse technology network set to make wavesA new network for research and technology in Southern Ontario’s…
Leafy green vertical farm opens in GuelphA state-of-the-art, fully automated 45,000 sq. ft. vertical farm is…
BC producer launches eight cannabis strains into marketPure Sunfarms formally launched its brand and introduced eight strains…
SAF ConferenceWed Sep 18, 2019
Ball Grower Day 2019Tue Sep 24, 2019
CIB SymposiumWed Sep 25, 2019
CanWestWed Sep 25, 2019
Canadian Greenhouse ConferenceWed Oct 09, 2019
PMA Fresh SummitThu Oct 17, 2019